On July 13, Hailier Pharmaceutical Group Co., Ltd. issued an announcement on the progress of purchasing 26% equity of Shaanxi Jinxinyi Chemical Technology Co., Ltd. in cash. On June 17, Hailier signed an "Investment Agreement" with Tongxue, Guo Qiangjun and Shaanxi Jin Xinyi. The

2024/06/2600:49:33 finance 1925
On July 13, Hailier Pharmaceutical Group Co., Ltd. issued an announcement on the progress of purchasing 26% equity of Shaanxi Jinxinyi Chemical Technology Co., Ltd. in cash. On June 17, Hailier signed an On July 13, Hailier Pharmaceutical Group Co., Ltd. issued an announcement on the progress of purchasing 26% equity of Shaanxi Jinxinyi Chemical Technology Co., Ltd. in cash. On June 17, Hailier signed an

On July 13, Hailier Pharmaceutical Group Co., Ltd. announced the progress of purchasing 26% equity of Shaanxi Jinxinyi Chemical Technology Co., Ltd. in cash.

On June 17, Hailier signed an "Investment Agreement" with Tongxue, Guo Qiangjun, and Shaanxi Jin Xinyi. The company plans to use its own funds to purchase the 26% equity of Shaanxi Jin Xinyi held by Guo Qiangjun for a transaction consideration of RMB 64.835 million.

Recently, Shaanxi Jinxinyi has completed the industrial and commercial change registration and filing procedures related to this equity transfer, and has obtained the "Business License" renewed by the Huazhou District Administrative Approval Service Bureau of Weinan City. The legal representative of the company: Guo Qiangjun; registered capital: 20 million yuan.

Shaanxi Jinxinyi is mainly engaged in the production and sales of 1,4-butanediol, γ-butyrolactone , α-acetyl-γ-butyrolactone , N-methylpyrrolidone , and chemical products. Among them, α-acetyl-γ-butyrolactone is one of the important intermediates of the company’s core fungicide product prothioconazole technical material. After the completion of this equity transaction of

Hailier, it will further enhance the stability of the core supply chain, enhance the company's overall ability to control the supply and quality of upstream raw materials, and deepen the company's strategic layout of intermediates and active pharmaceutical ingredients; at the same time, it will be conducive to strengthening the The strategic cooperation and industrial coordination between the two parties will help both parties further integrate their own advantageous resources, create greater value for the cooperation between the two parties, and help establish a long-term, stable, mutually beneficial and win-win comprehensive strategic partnership, and continuously improve both parties and their affiliated institutions. depth and breadth of cooperation at multiple levels. This cash transaction is in line with the company's development strategy, is conducive to the company's future business development and financial status, and is conducive to enhancing the company's comprehensive competitiveness.

Source: Company announcement

On July 13, Hailier Pharmaceutical Group Co., Ltd. issued an announcement on the progress of purchasing 26% equity of Shaanxi Jinxinyi Chemical Technology Co., Ltd. in cash. On June 17, Hailier signed an

Stabilize the economy and ensure operation, and focus on the economy to promote development - the 9th Pesticide Industry Economic Operation Analysis Conference and the 2022 Pesticide Industry List Press Conference were successfully held

China Pesticide Industry Association was selected into the first batch of National Development and Reform Commission "Brands" Association Growth Plan"

Regarding the convening of the "22nd National Pesticide Exchange Conference and Agrichemical Products Exhibition", the "7th China International Fertilizer and Agricultural Equipment Exhibition", and the "5th Modern Agricultural Service Exhibition" Notice

Notice on launching a pilot application for ecologically friendly and environmentally friendly high-quality agricultural inputs (pesticide plant protection products)

Notice on applying for green and high-quality pesticide products

China’s Pesticide Price Index in May 2022

finance Category Latest News